A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Clinical trial NCT02991469 · RECRUITING
Trial details
- NCT number
- NCT02991469
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2028-03-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.